<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Boscarino G</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Prolonged mechanical ventilation, commonly used to assist preterm newborns, increases the risk of developing bronchopulmonary dysplasia (BPD). In recent decades, studies have demonstrated that systemic corticosteroids play a significant role in the prevention and management of BPD. In this systematic review of randomized controlled trials (RCTs), we evaluated the association between the administration of systemic corticosteroids in preterm infants and its long-term outcomes, such as neurodevelopment, growth, extubation rate, and related adverse effects.&lt;h4>Methods&lt;/h4>We conducted an electronic search in Medline, Scopus, and PubMed using the following terms: "premature infants" and "corticosteroids." We considered all RCTs published up to June 2023 as eligible. We incl</pubmed_abstract><journal>Frontiers in pediatrics</journal><pagination>1344337</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10899705</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Outcomes of postnatal systemic corticosteroids administration in ventilated preterm newborns: a systematic review of randomized controlled trials.</pubmed_title><pmcid>PMC10899705</pmcid><pubmed_authors>Boscarino G</pubmed_authors><pubmed_authors>Terrin G</pubmed_authors><pubmed_authors>Liguori F</pubmed_authors><pubmed_authors>Repole P</pubmed_authors><pubmed_authors>Conti MG</pubmed_authors><pubmed_authors>Cardilli V</pubmed_authors><pubmed_authors>Parisi P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Outcomes of postnatal systemic corticosteroids administration in ventilated preterm newborns: a systematic review of randomized controlled trials.</name><description>&lt;h4>Introduction&lt;/h4>Prolonged mechanical ventilation, commonly used to assist preterm newborns, increases the risk of developing bronchopulmonary dysplasia (BPD). In recent decades, studies have demonstrated that systemic corticosteroids play a significant role in the prevention and management of BPD. In this systematic review of randomized controlled trials (RCTs), we evaluated the association between the administration of systemic corticosteroids in preterm infants and its long-term outcomes, such as neurodevelopment, growth, extubation rate, and related adverse effects.&lt;h4>Methods&lt;/h4>We conducted an electronic search in Medline, Scopus, and PubMed using the following terms: "premature infants" and "corticosteroids." We considered all RCTs published up to June 2023 as eligible. We incl</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-26T04:12:17.644Z</modification><creation>2025-04-06T11:01:12.525Z</creation></dates><accession>S-EPMC10899705</accession><cross_references><pubmed>38419972</pubmed><doi>10.3389/fped.2024.1344337</doi></cross_references></HashMap>